- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- Analysis
- Focus Articles1 new
- Related Articles
- Instablogs
- StockTalks
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts1 new
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
CHTP Market Currents
more »
CHTP in Focus
more »
CHTP Related Articles
more »
CHTP News
more »
-
at MarketWatch.com (Feb 24, 2012)
-
at MarketWatch.com (Feb 24, 2012)
-
at MarketWatch.com (Feb 13, 2012)
-
at MarketWatch.com (Jun 20, 2011)
-
at MarketWatch.com (Jun 10, 2011)
CHTP Press Releases and Filings
more »
-
GlobeNewswire (Tue, 7:00AM)
-
GlobeNewswire (May 1, 2012)
-
GlobeNewswire (May 1, 2012)
-
GlobeNewswire (Apr 27, 2012)
-
GlobeNewswire (Apr 25, 2012)
CHTP Latest Transcript
more »
CHTP Cramer
more »
Currently, there are no Cramer articles on CHTP.
CHTP Instablog posts
more »
CHTP vs. ETF Alternatives
Company Description
We are a development stage pharmaceutical company that seeks to acquire, develop and commercialize innovative products for the treatment of a variety of human diseases. Our strategy is to develop technologies that address important unmet medical needs or offer improved, cost-effective... More
